ATS 2024 Final Program

Click on the session title to view the speakers

165

MONDAY • MAY 20

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

BASIC THEMATIC POSTER SESSION

B61 THE NEED FOR SPEED: ARTIFICIAL INTELLIGENCE IN PVD 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P145 Artificial Intelligence Applied to Chest Computed Tomography: Pulmonary Artery Volume as an Image Marker of Pulmonary Hypertension P146 AI-driven PE Detection and RV/LV Ratio Measurement: A Preliminary Validation Study P147 Early Prediction of Pulmonary Hypertension Using Artificial Intelligence-enabled Electrocardiogram P148 Leveraging Artificial Intelligence to Measure Left Atrial Size to Identify Left Heart Disease in Suspected Pulmonary Hypertension P149 The Pitfalls of Artificial Intelligence in Management of Pulmonary Embolism and Pulmonary Embolism Response Team Activation P150 Evaluating the Efficacy of ChatGPT in Pulmonary Embolism Triage: Insights From the Pert Algorithm Study P151 Use of Machine Learning Models to Identify Patients With Pulmonary Embolism From Radiologic Reports P152 Real World Assessment of Artificial Intelligence for Pulmonary Embolism Detection and Risk Stratification San Diego Convention Center Area B (Hall A-B2, Ground Level)

B62 A LEGO STORY: MOLECULAR

BUILDING BLOCKS IN PULMONARY HYPERTENSION

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area A (Hall A-B2, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P23 Novel Proteins Implicated in Extracellular Matrix Remodeling and Angiogenesis Are Upregulated in Pulmonary Arterial Hypertension P24 Loss of RASA3 Leads to Decreased BMPR2 Signaling in Pulmonary Artery Endothelial Cells and Microvascular Lung Endothelial Cells P25 Protective Role of Fibroblast Growth Factors in Group 3 Hypoxia Induced Pulmonary Hypertension P26 Closing Walls and Ticking Clocks: Pulmonary Vascular Remodeling Checked by Vascular Smooth Muscle Cell Depletion of BMAL1 P27 Endothelin-2 Underlies Sex Differences in Vascular Remodeling in Pulmonary Hypertension P28 Therapeutic Effect of Bromocriptine on Pulmonary Hypertension P29 Synthesis of CeO2@BSA Nanoclusters for Inhibition of Pulmonary Microvascular Endothelial Cell Dysfunction and Improvement of Rat Vascular Reconstitution P30 Therapeutic Effect of Levosulpride on Pulmonary Hypertension P31 Honokiol Improves Exercise Endurance In Sugen/Hypoxia-Induced Pulmonary Hypertensive Rats Through Increasing SIRT3 Function P32 A Novel Mechanism Regulating Aquaporin 1 Abundance in Pulmonary Arterial Smooth Muscle Cells P33 Soluble Adenylyl Cyclase Inhibition Attenuates the Abnormal Endothelial Cell Phenotype Associated With Caveolin-1 Loss-of-Function

ATS 2024 Conference Program • San Diego, CA